The promoter region of
telomerase reverse transcriptase (TERTp) and
isocitrate dehydrogenase (IDH) have been regarded as
biomarkers with distinct clinical and phenotypic features. Investigated the possible correlations between
tumor location and genetic alterations would enhance our understanding of gliomagenesis and heterogeneity of
glioma. We examined mutations of TERTp and IDH by direct sequencing and fluorescence in-situ hybridization in a cohort of 225 grades II and III diffuse
gliomas. Correlation analysis between molecular markers and
tumor locations was performed by Chi-square tests/Fisher's exact test and multivariate logistic regression analysis. We found
gliomas in frontal lobe showed higher frequency of TERTp mutation (P=0.0337) and simultaneously mutations of IDH and TERTp (IDH (mut)-TERTp(mut)) (P=0.0281) than frequency of
biomarkers mutation of
tumors in no-Frontal lobes, while lower frequency of TERTp mutation (P<0.0001) and simultaneously wild type of IDH and TERTp (IDH (wt)-TERTp(wt)) (P<0.0001) in midline than no-midline lobes. Logistic regression analysis indicated that locations of
tumors associated with TERTp mutation (OR=0.540, 95% CI 0.324-0.900, P=0.018) and status of combinations of IDH and TERTp (IDH (mut)-TERTp (mut) vs. IDH (wt)-TERTp (wt) OR=0.162, 95% CI 0.075-0.350, P<0.001). In conclusion, grades II and III
gliomas harboring TERTp mutation were located preferentially in the frontal lobe and rarely in midline. Association of IDH-TERTp status and
tumor location suggests their potential values in molecular classification of grades II and III
gliomas.